X4 Pharmaceuticals, Inc. (XFOR)

NCM – Real Time Price. Currency in USD

4.34

+0.06 (1.40%)

Market open: Aug 12, 2026, 10:49 AM EDT

4.28

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

35M

Cost of goods sold

-6M

-1M

-2M

Gross Profit

29M

-2M

Operating expenses (excl. COGS)

-116M

-143M

-106M

-86M

Operating Income

-87M

-141M

-108M

-88M

Non-operating income, total

104M

-6M

Pretax income

-79M

-37M

-101M

-94M

Equity in earnings

Taxes

-41K

-310K

-78K

-28K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-79M

-37M

-101M

-94M

Discontinued operations

Net income

-79M

-37M

-101M

-94M

Dilution adjustment

Preferred dividends

X4 Pharmaceuticals, Inc. (XFOR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

X4 Pharmaceuticals, Inc. (XFOR)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

X4 Pharmaceuticals, Inc. (XFOR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

X4 Pharmaceuticals, Inc. (XFOR)

Income Statement (Annual)

Income Statement (Annual)